We hear that a big Romanian healthcare service group recently turned down a bid from Acibadem, the Turkish (and now Bulgarian) hospital group owned by IHH, the Pan-Asian hospital group. Meanwhile, the Bucharest hospital market is hotting up.
Under-penetrated and underserved markets in CEE are becoming too tempting to ignore for investors, claims Turkey-based regional expert Ufuk Eren, CEO of Volitan Consulting and advisor to EY. He spoke to Healthcare Europa at HBI 2018 in London and shared his thoughts about where he would recommend investing – and why.
The top private healthcare operators in Romania will continue to expand despite ongoing political instability leading to constant government reshuffles, industry insiders told Healthcare Europa at HBI 2018.
We hear that Czechia-based Penta Investment's acquisition of A&D Pharma, the largest pharma chain and distribution business in Romania, will close at the upper end of local media estimates.
Romania is set to increase its public healthcare budget in 2018 which could potentially impact private healthcare operators - but industry insiders are telling Healthcare Europa they are sceptical as to whether it will actually happen given the political instability and government funding problems in the country.
Strong organic growth at 14.5% was at the core of a robust set of results for German, East-European and Indian outpatient, hospital and lab group Medicover which announced its maiden results post its summer 2017 IPO.
Despite radical reforms and a government implacably opposed to opening up markets to private operators, there’s still money to be made in Polish healthcare if you know where to look. Healthcare Europa speaks to a well-placed local investor who believes anyone taking a long-term view can still find Poland profitable.
Unilever runs a global health and prevention programme in over 90 countries for its 169,000 employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
Unilever runs a global health and prevention programme in over 90 countries for its 169,000 employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.